SARS-CoV-2 Nucleic Acid detection Kit(R≥∞→φeal-time PCR)

【Background】

In 2020, an unexpected ♠★₽®outbreak swept the world. The main pathogen caus♣φing the outbreak is SARS-CoV•↕-2, a new virus that r←€esearchers first identified in £ε∑Wuhan province, Chinσ₽₹a, in late 2019, and was named by thφ÷e World Health Organ✘$§®ization on January 12, ↔₩±₩2020. It is a pathogen ↓♥ that mainly causes respiratory and in♠‌testinal diseases.
The epidemic coincided wit♦¥h the Spring Festival in 2020, and the developme←α→nt was very fierce and spread widely. A♦π‍‍s an industrial national high-tech enterpr'≠ ↓ise for the detection and development of re¥¶✘$spiratory pathogens, our δ‍ company joined the "battle" as soonλ∏✘♥ as possible and quickly ≤&"organized the strongest R & D force ₩‌πto succeed Develop high-sensitiπ vity detection kits to fight agaσ±inst viruses and help the fron >•tline fight against epidemics!

【Clinical Manifestations】

Based on the current epidemiological surve→×πy, the incubation period for 2019-✘Ω✔✔nCoV is generally 3-7 days, with a maxiγγmum of 14 days. The clinical manifestation≤λs of the virus infection are: fever, fatigue, rγ÷espiratory symptoms are m εainly dry cough, and dy©γ spnea gradually develops; se♣≈$↕vere cases present with acut₹∏₹•e respiratory distress syndrome, septic ☆±shock, metabolic acidosis and coa↑&☆₩gulation that are difficult to treat; some pa↑™×↓tients have mild onset×∏★≥ symptoms but no fever; most patients have a goλ© ©od prognosis, and a few patients are in critical ↓¶©♦ condition or even die. The disease cau$¥sed by the virus can be manifested as s÷γ★imple infection, mild pΩ ↑neumonia, severe pneumonia, ARDS, sepsis, and§λ‍ septic shock. According ↑ to the severity of clinical sy≥<♣ndrome, it is divided into mild, moderate✘↑÷‌ and severe, the latter includ>↕™¶ing severe pneumonia, ARDS, ←π sepsis and septic shock. φ¥

【Product Features】

Based on real-timα≈e fluorescent PCR teα$chnology, the results are prα‌¶₩oduced within 1.5 hourβ♣s.

The reaction system of×↔® this kit contains a dU-UNG enzyme anti-pollut∏φion system to avoid fal↕↔✔se positive results; the system contains i←♠♥‍nternal standards to avoidγ₽ false negative results.

Taking the highly conserved regi★ ↕&ons of the ORF1ab and N gene"★₹∑s in the genome of the new coronaviru→♣≥s (2019-nCoV) as target regions, specific priπ mers and fluorescent₩α≤ probes were designed to pe↕©§✔rform PCR amplificati↓★¶on to ensure the accuracy of th™ e product.

【Product performances】

Sensitivity	1.0x10³copies/mL
Linear range	1.0x10³copies/mL ~ 1.0x 10⁹copies/mL
Accuracy	100% in enterprise references
Precision	Coefficient of variation (CV) ≤5%&nb≈•γsp;within and between batchesδ≤≤¶
Specificity	No cross-reaction with coronavirus (NL63¶β>→, HKU1, 229E, OC43), influenza A×>∞ virus, influenza B virus, respirat₹£₽♦ory syncytial virus, adenovir≈ ¥us, mycoplasma pneumonia, and bordetell♥₩↓←a pertussis.
Interference	Not affect by Interferon (α-2b≤180 μg/mL), Hσ₽↓ydroxymezoline hydrochloride spray(±≥♥≤150 μg /mL), Budesonide nasal spra®×y(≤256 g /mL), Erythromycin(≤50 mg/mL), Roxithroπ§φmycin (≤7.5 mg/mL), Azithromycin (≤ '↔β100mg/mL).